Genexine (Korea) Price History

095700 Stock  KRW 5,840  210.00  3.47%   
If you're considering investing in Genexine Stock, it is important to understand the factors that can impact its price. As of today, the current price of Genexine stands at 5,840, as last reported on the 1st of December, with the highest price reaching 6,170 and the lowest price hitting 5,810 during the day. Genexine holds Efficiency (Sharpe) Ratio of -0.0295, which attests that the entity had a -0.0295% return per unit of risk over the last 3 months. Genexine exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Genexine's Standard Deviation of 4.84, market risk adjusted performance of 0.6884, and Risk Adjusted Performance of (0.03) to validate the risk estimate we provide.
  
Genexine Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0295

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns095700

Estimated Market Risk

 5.01
  actual daily
44
56% of assets are more volatile

Expected Return

 -0.15
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.03
  actual daily
0
Most of other assets perform better
Based on monthly moving average Genexine is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genexine by adding Genexine to a well-diversified portfolio.

Genexine Stock Price History Chart

There are several ways to analyze Genexine Stock price data. The simplest method is using a basic Genexine candlestick price chart, which shows Genexine price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceOctober 17, 20249350.0
Lowest PriceNovember 22, 20245650.0

Genexine December 1, 2024 Stock Price Synopsis

Various analyses of Genexine's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Genexine Stock. It can be used to describe the percentage change in the price of Genexine from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Genexine Stock.
Genexine Price Rate Of Daily Change 0.97 
Genexine Price Action Indicator(255.00)
Genexine Price Daily Balance Of Power(0.58)

Genexine December 1, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Genexine Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Genexine intraday prices and daily technical indicators to check the level of noise trading in Genexine Stock and then apply it to test your longer-term investment strategies against Genexine.

Genexine Stock Price History Data

The price series of Genexine for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 has a statistical range of 3700.0 with a coefficient of variation of 13.89. The prices are distributed with arithmetic mean of 6802.73. The median price for the last 90 days is 6380.0. The company had 13:10 stock split on 11th of January 2023.
OpenHighLowCloseVolume
12/01/2024
 6,050  6,170  5,810  5,840 
11/29/2024 6,050  6,170  5,810  5,840  234,630 
11/28/2024 6,030  6,120  5,950  6,050  137,583 
11/27/2024 5,980  6,070  5,900  6,030  229,636 
11/26/2024 6,000  6,230  5,860  5,880  439,687 
11/25/2024 5,650  5,880  5,630  5,880  181,386 
11/22/2024 5,680  5,770  5,590  5,650  206,925 
11/21/2024 5,750  5,770  5,570  5,680  215,228 
11/20/2024 5,810  5,990  5,720  5,730  255,246 
11/19/2024 5,980  6,040  5,850  5,850  243,207 
11/18/2024 6,000  6,090  5,830  5,980  196,057 
11/15/2024 6,050  6,100  5,860  6,000  234,289 
11/14/2024 6,150  6,500  6,050  6,080  316,138 
11/13/2024 6,470  6,540  6,140  6,200  346,944 
11/12/2024 6,900  6,970  6,440  6,480  449,577 
11/11/2024 6,860  6,970  6,730  6,970  185,111 
11/08/2024 6,760  7,090  6,760  6,950  259,669 
11/07/2024 7,030  7,070  6,660  6,760  363,987 
11/06/2024 7,270  7,380  6,910  7,070  583,610 
11/05/2024 7,450  7,500  7,150  7,180  359,538 
11/04/2024 7,370  7,470  7,140  7,450  393,387 
11/01/2024 7,320  7,650  7,140  7,370  647,197 
10/31/2024 7,640  7,710  7,220  7,320  731,535 
10/30/2024 8,090  8,090  7,830  7,850  450,479 
10/29/2024 8,040  8,130  7,810  8,110  494,083 
10/28/2024 8,330  8,330  7,820  8,040  942,537 
10/25/2024 8,800  8,840  8,100  8,400  1,201,441 
10/24/2024 8,490  9,450  8,450  8,900  1,959,561 
10/23/2024 8,970  9,680  8,570  8,800  3,820,315 
10/22/2024 8,850  9,930  8,380  8,650  6,648,862 
10/21/2024 9,500  9,510  8,720  8,980  1,846,594 
10/18/2024 9,660  9,950  9,220  9,350  3,947,955 
10/17/2024 8,200  10,230  7,430  9,350  23,034,929 
10/16/2024 6,200  8,170  6,200  8,170  3,900,535 
10/15/2024 6,240  6,370  6,230  6,290  67,100 
10/14/2024 6,320  6,400  6,180  6,290  50,087 
10/11/2024 6,450  6,460  6,300  6,310  61,792 
10/10/2024 6,420  6,490  6,330  6,400  46,716 
10/08/2024 6,310  6,610  6,310  6,410  109,389 
10/07/2024 6,230  6,400  6,140  6,330  71,520 
10/04/2024 6,100  6,250  6,080  6,200  34,415 
10/02/2024 6,160  6,210  6,000  6,080  74,982 
09/30/2024 6,250  6,290  6,130  6,160  68,636 
09/27/2024 6,410  6,520  6,300  6,300  71,792 
09/26/2024 6,390  6,450  6,310  6,380  63,036 
09/25/2024 6,400  6,590  6,310  6,310  72,148 
09/24/2024 6,330  6,570  6,290  6,360  97,912 
09/23/2024 6,510  6,510  6,310  6,330  59,442 
09/20/2024 6,400  6,440  6,280  6,370  86,995 
09/19/2024 6,140  6,350  6,140  6,290  89,775 
09/13/2024 6,230  6,290  6,090  6,140  90,295 
09/12/2024 6,220  6,410  6,030  6,280  241,749 
09/11/2024 6,210  6,400  6,200  6,210  66,900 
09/10/2024 6,260  6,340  6,170  6,200  80,050 
09/09/2024 5,910  6,810  5,910  6,260  379,600 
09/06/2024 6,280  6,350  6,080  6,080  95,036 
09/05/2024 6,430  6,460  6,220  6,270  79,965 
09/04/2024 6,560  6,600  6,320  6,420  115,275 
09/03/2024 6,910  6,910  6,620  6,630  72,681 
09/02/2024 7,070  7,090  6,780  6,820  88,948 
08/30/2024 6,910  7,140  6,910  7,070  77,776 

About Genexine Stock history

Genexine investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Genexine is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Genexine will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Genexine stock prices may prove useful in developing a viable investing in Genexine
Genexine, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of immunotherapeutics and long-acting biologics in South Korea. Genexine, Inc. was founded in 1999 and is based in Seongnam, South Korea. Genexine is traded on Korean Securities Dealers Automated Quotations in South Korea.

Genexine Stock Technical Analysis

Genexine technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Genexine technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Genexine trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Bonds Directory Now

   

Bonds Directory

Find actively traded corporate debentures issued by US companies
All  Next Launch Module

Genexine Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Genexine's price direction in advance. Along with the technical and fundamental analysis of Genexine Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Genexine to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Genexine Stock analysis

When running Genexine's price analysis, check to measure Genexine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genexine is operating at the current time. Most of Genexine's value examination focuses on studying past and present price action to predict the probability of Genexine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genexine's price. Additionally, you may evaluate how the addition of Genexine to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios